Core C: Histopathology and Histomorphometry Core
Core C: Histopathology and Histomorphometry Core
批准号:
10246814
负责人:
VOLKHARD LINDNER
金额:
$16.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-08-31
关键词:
AddressAntigensBiochemical PathwayBiologyBlood VesselsCellsCellular biologyCenters of Research ExcellenceClientCore FacilityData SetEquipmentFacultyFreezingFundingFunding AgencyFunding MechanismsGoalsHistological TechniquesHistopathologyHuman ResourcesImmunohistochemistryInstitutesInvestmentsMaineMedical centerMesenchymalMineralsNational Institute of General Medical SciencesParaffin EmbeddingPhasePlastic EmbeddingProceduresProtocols documentationPublicationsQuality ControlResearchResearch AssistantResearch PersonnelResource SharingResourcesRetrievalScientific Advances and AccomplishmentsServicesSideSisterSourceSpecimen HandlingStandardizationStrategic PlanningTimeTissue MicroarrayTissue StainsTissuesTrainingWait Timebonecalcificationdetection methodexperienceexperimental studyhistological stainsimprovedinstrumentationmedical specialtiesmemberneuroregulationrecruitsample fixationskeletalskeletal tissuestem cellssuccesstissue archivetissue processing
中文摘要
目前的组织病理学核心是在2004年建立的干细胞和祖细胞科布雷
细胞生物学(8P20GM103465),Volkhard Lindner博士为核心主任。包括的服务
冰冻切片和石蜡包埋切片的固定、包埋和加工
常规和特殊的组织学染色和基本免疫组织化学的光谱。我们的工作人员有
开发和优化免疫组织化学程序的专业知识,包括抗原检索,
在档案组织中的优化,以及各种检测方法。这一核心的成功吸引了
来自我们血管生物学的姐妹Cobre,缅因州医学中心的其他研究人员,以及
地区性客户,包括来自邻近创意国家的客户。我们的服务需求量很大,并被引入
2011给我们的血管生物学科布雷(P30GM103392)共同资助组织病理学核心到
增加研究人员以扩大能力,并增加组织微阵列服务。这项联合资助
这一机制非常有效,能够有效地扩大服务。核心和它的
现有工作人员(核心主任和两名全职工作人员)执行40,000多个程序
每年,并在过去十年中直接支持了90多种出版物。当前使用情况为
再次达到容量,以及在间质和神经调节方面的第一阶段的新项目
新陈代谢网络需要广泛的组织处理和组织病理学服务,并有新的需求
用于骨骼组织处理和组织形态计量学,这在我们的
研究所。因此,作为Cobre应用程序的一部分,我们建议将现有的Core扩展为
组织病理学和组织形态计量学核心,增加一名工作人员和新的骨骼
组织形态计量学服务。建立矿化组织和骨骼的组织学技术
组织形态计量学将满足我们的Cobre项目和其他项目对这些服务的迫切需求
目前使用该核心的研究人员。这反过来将增加我们的竞争力
研究人员通过推进科学进步。该核心将充分利用现有设备和
在NIGMS的鼓励下,从之前的Cobre支持中获得了工具。我们的战略
本申请中提出的扩展与任何现有资金来源都不重叠。这个
该提案的具体目标是:1)满足不断增长的需求,并通过以下方式支持Cobre项目
支持一名新的全职工作人员;2)建立新的塑料嵌入和切片,以允许
对钙化组织的扩展分析,以及3)建立新的骨组织形态计量学服务
支持科布雷项目和其他需要骨骼分析的调查人员。
英文摘要
The current Histopathology Core was established in 2004 within the COBRE in Stem and Progenitor
Cell Biology (8P20GM103465), with Dr. Volkhard Lindner as the Core Director. Services included
fixation, embedding, and processing of specimens for frozen and paraffin embedded sections and a
spectrum of routine and specialty histological stains and basic immunohistochemistry. Our staff has
expertise to develop and optimize immunohistochemistry procedures, including antigen retrieval,
optimization in archival tissues, and various detection methods. The success of this Core attracted
users from our sister COBRE in Vascular Biology, other investigators at Maine Medical Center, and
regional clients, including from neighboring IDeA states. Our services were in high demand, and led in
2011 to our COBRE in Vascular Biology (P30GM103392) co-funding the Histopathology Core to
increase research staff for expanded capacity, and add tissue microarray services. This co-funding
mechanism has been extremely effective, allowing for efficient expansion of services. The Core with its
current staff (Core Director and two full-time staff members) performs more than 40,000 procedures
annually, and in the past ten years has directly supported over ninety publications. Current usage is
again at capacity, and the new projects in this Phase I COBRE in Mesenchymal and Neural Regulation
of Metabolic Networks require extensive tissue processing and histopathology services, with new needs
for skeletal tissue processing and histomorphometry, which previously were not supported at our
Institute. Thus, as part of this COBRE application, we propose an expansion of the existing Core into
the Histopathology and Histomorphometry Core, with one additional staff member and new skeletal
histomorphometry services. Establishing histological techniques for mineralized tissues and bone
histomorphometry will meet the urgent demand for these services by our COBRE projects and other
researchers who currently utilize this Core. This in turn will increase the competitiveness of our
investigators by advancing scientific progress. This Core will fully utilize the existing equipment and
instrumentation garnered from previous COBRE support, as encouraged by NIGMS. Our strategic
expansion proposed in this application is non-overlapping with any current funding source. The
specific aims of this proposal are to: 1) meet growing need and support COBRE projects by
supporting a new full-time staff member, 2) establish new plastic embedding and sectioning to allow for
expanded analysis of calcified tissues, and 3) establish new bone histomorphometry services to
support the COBRE projects and other investigators requiring skeletal analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating the mechanisms underlying heart valve endothelial repair
-
批准号:10586074
-
项目类别:
-
资助金额:$49.35万
-
财政年份:2022
-
负责人:VOLKHARD LINDNER
-
依托单位:
Delineating the mechanisms underlying heart valve endothelial repair
-
批准号:10464257
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2022
-
负责人:VOLKHARD LINDNER
-
依托单位:
Effect of CTHRC1 on endothelial cell survival after acute ischemia
-
批准号:10531574
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:VOLKHARD LINDNER
-
依托单位:
Effect of CTHRC1 on endothelial cell survival after acute ischemia
-
批准号:9885606
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:VOLKHARD LINDNER
-
依托单位:
Effect of CTHRC1 on endothelial cell survival after acute ischemia
-
批准号:10312789
-
项目类别:
-
资助金额:$53.46万
-
财政年份:2019
-
负责人:VOLKHARD LINDNER
-
依托单位:
Histopathology and Microscopy Core
-
批准号:10711695
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2017
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:8360263
-
项目类别:
-
资助金额:$10.96万
-
财政年份:2011
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:8167686
-
项目类别:
-
资助金额:$10.56万
-
财政年份:2010
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:7960392
-
项目类别:
-
资助金额:$10.29万
-
财政年份:2009
-
负责人:VOLKHARD LINDNER
-
依托单位:
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1
-
批准号:7959657
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2009
-
负责人:VOLKHARD LINDNER
-
依托单位:
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1
-
批准号:7720097
-
项目类别:
-
资助金额:$18.87万
-
财政年份:2008
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:7720703
-
项目类别:
-
资助金额:$11.06万
-
财政年份:2008
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:7610631
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2007
-
负责人:VOLKHARD LINDNER
-
依托单位:
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CTHRC-1
-
批准号:7609691
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2007
-
负责人:VOLKHARD LINDNER
-
依托单位:
CONTROL OF VASCULAR FIBROSIS AND COLLAGEN DEPOSITION BY NOVEL REGULATOR, CRHRC-1
-
批准号:7381068
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2006
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE C: HISTOPATHOLOGY CORE
-
批准号:7382096
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2006
-
负责人:VOLKHARD LINDNER
-
依托单位:
COBRE: MAINE MED CTR: CORE C: PATHOLOGY CORE
-
批准号:7171325
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2005
-
负责人:VOLKHARD LINDNER
-
依托单位:
CORE--PATHOLOGY
-
批准号:6981990
-
项目类别:
-
资助金额:$8.52万
-
财政年份:2004
-
负责人:VOLKHARD LINDNER
-
依托单位:
Remodelin, a Novel Vascular Injury and Bone Related Gene
-
批准号:6933808
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:VOLKHARD LINDNER
-
依托单位:
Cthrc1 function as a novel TGF-beta antagonist in the vasculature
-
批准号:8419303
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2002
-
负责人:VOLKHARD LINDNER
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: